Newsroom
April 10, 2026
The BioFest Days brought the community together April 7, for an evening of discovery and connection at the UT Health San Antonio Center for Brain Health. Hosted as part of the 12-day, citywide celebration of biomedical advancement organized by BioMed SA, the event invited attendees to explore how research, clinical care and community involvement […]
March 24, 2026
UT Health San Antonio Multispecialty and Research Hospital has enrolled and treated its first clinical trial participant in a novel cancer study, marking a pivotal moment for science and patient-centered cancer care in San Antonio and South Texas.
September 8, 2025
The University of Texas at San Antonio Health Science Center has been recognized among the top 2.4% of universities worldwide in the 2025 Center for World University Rankings (CWUR), reaffirming its position as a global leader in biomedical discovery and innovation.
April 18, 2025
Discovery of chemical endocytosis could redefine precision medicine A team of scientists, notably Zhengyu Wang, PhD, assistant professor in the department of pharmacology and the Barshop Institute, led by Hong-yu Li, PhD, professor of medicinal chemistry and chemical biology with the department of pharmacology and the Barshop Institute at The University of Texas Health Science […]
January 22, 2025
Since the discovery of antibiotics, physicians have grappled with the inevitability of bacterial resistance to antibiotics. This challenge has become increasingly urgent, with antibiotic resistance projected to cause 39 million deaths between 2025 and 2050, according to the World Health Organization. By 2050, the organization also predicts these infections will surpass cancer as the leading […]
September 30, 2024
Charles P. France, PhD, to lead methocinnamox drug development program The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was awarded a $12 million cooperative agreement (U01) from the National Institutes of Health’s National Institute on Drug Abuse to further develop methocinnamox (MCAM) as a treatment for opioid use disorder. […]